Changeflow GovPing Drug Safety Cytosar (cytarabinum) Barcode Expiry Date Discr...
Priority review Notice Amended Final

Cytosar (cytarabinum) Barcode Expiry Date Discrepancy Alert

Favicon for www.swissmedic.ch Swissmedic Health Professional Communications
Published February 18th, 2026
Detected March 12th, 2026
Email

Summary

Swissmedic has issued a Health Professional Communication regarding a barcode expiry date discrepancy for Cytosar (cytarabinum) 2g/20ml, batch CT32407B. The date encoded in the 2D barcode on the vial label is incorrect and does not match the legible expiry date printed on the vial.

What changed

Swissmedic, the Swiss Agency for Therapeutic Products, has issued a Health Professional Communication (DHPC) concerning a specific batch of Cytosar (cytarabinum) 2g/20ml, batch number CT32407B. The issue identified is a discrepancy where the expiry date encoded in the 2D barcode on the vial label is incorrect and does not align with the legible expiry date printed on the vial itself. This alert pertains to a single affected batch, and further details are available in a separate company information letter.

Healthcare providers and potentially pharmaceutical distributors handling this specific batch should be aware of this discrepancy. While the legible expiry date on the vial is stated to be correct, the incorrect barcode information could lead to errors in inventory management or automated dispensing systems. It is recommended to consult the company's information letter for precise instructions and to ensure proper handling and dispensing of this medication to avoid potential patient safety issues arising from incorrect expiry date interpretation.

What to do next

  1. Review company information letter regarding Cytosar (cytarabinum) batch CT32407B
  2. Verify expiry dates on affected vials against legible print and barcode data
  3. Ensure proper handling and dispensing procedures are followed to account for the barcode discrepancy

Source document (simplified)

Context sidebar

DHPC – Cytosar (cytarabinum)

Diskrepanz Barcode

18.02.2026

| Präparat | Cytosar 2g/20ml, Injektionslösung |
| --- | --- |
| Zulassungsnummer | 54845 |
| Wirkstoff | cytarabinum |
| Zulassungsinhaberin | Pfizer AG |
| Betroffene Charge | CT32407B |

Das im 2D-Barcode des Fläschchenetiketts kodierte Verfallsdatum ist falsch und stimmt nicht mit dem auf dem Fläschchenetikett aufgedrucktem lesbarem Format überein.

Weitere Informationen entnehmen Sie bitte dem Informationsschreiben der Firma.


- Company information letter
DHPC – Cytosar (cytarabinum) (PDF, 210 kB, 13.02.2026)

Top of page

Classification

Agency
Various
Published
February 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Drug manufacturers Healthcare providers
Geographic scope
National (Switzerland)

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Compliance
Topics
Product Safety Supply Chain

Get Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when Swissmedic Health Professional Communications publishes new changes.

Free. Unsubscribe anytime.